ArticleFrontiers in pharmacology2025
Brain-derived uroguanylin as a regulator of postprandial brown adipose tissue activation: a potential therapeutic approach for metabolic disorders.
Nikola Habek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.